Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Malignant Lymphoma

  Free Subscription

Articles published in Cancer Res

Retrieve available abstracts of 14 articles:
HTML format

Single Articles

    January 2022
  1. DEVIN J, Caneque T, Lin YL, Mondoulet L, et al
    Targeting cellular iron homeostasis with ironomycin in diffuse large B cell lymphoma.
    Cancer Res. 2022 Jan 25. pii: 0008-5472.CAN-21-0218.
    PubMed     Abstract available

    December 2021
  2. SZYDLOWSKI M, Garbicz F, Jablonska E, Gorniak P, et al
    Inhibition of PIM Kinases in DLBCL Targets MYC Transcriptional Program and Augments the Efficacy of Anti-CD20 Antibodies.
    Cancer Res. 2021;81:6029-6043.
    PubMed     Abstract available

    November 2021
  3. DHURI K, Gaddam RR, Vikram A, Slack FJ, et al
    Therapeutic Potential of Chemically Modified, Synthetic, Triplex Peptide Nucleic Acid-Based Oncomir Inhibitors for Cancer Therapy.
    Cancer Res. 2021;81:5613-5624.
    PubMed     Abstract available

    October 2021
  4. CALVO-VIDAL MN, Zamponi N, Krumsiek J, Stockslager MA, et al
    Oncogenic HSP90 Facilitates Metabolic Alterations in Aggressive B-cell Lymphomas.
    Cancer Res. 2021;81:5202-5216.
    PubMed     Abstract available

    September 2021
  5. SOSHNEV AA, Allis CD, Cesarman E, Melnick AM, et al
    Histone H1 mutations in lymphoma: a link(er) between chromatin organization, developmental reprogramming, and cancer.
    Cancer Res. 2021 Sep 27. pii: 0008-5472.CAN-21-2619.
    PubMed     Abstract available

    June 2021
  6. SPASEVSKA I, Myklebust JH
    What It Takes to Transform a T Cell.
    Cancer Res. 2021;81:3160-3161.
    PubMed     Abstract available

  7. PAWLICKI JM, Cookmeyer DL, Maseda D, Everett JK, et al
    NPM-ALK-Induced Reprogramming of Mature TCR-Stimulated T Cells Results in Dedifferentiation and Malignant Transformation.
    Cancer Res. 2021;81:3241-3254.
    PubMed     Abstract available

    May 2021
  8. LEE CL, Brock KD, Hasapis S, Zhang D, et al
    Whole exome sequencing of radiation-induced thymic lymphoma in mouse models identifies Notch1 activation as a driver of p53 wild-type lymphoma.
    Cancer Res. 2021 May 25. pii: 0008-5472.CAN-20-2823.
    PubMed     Abstract available

    December 2020
  9. FARRIA AT, Plummer JB, Salinger AP, Shen J, et al
    Transcriptional Activation of MYC-Induced Genes by GCN5 Promotes B-cell Lymphomagenesis.
    Cancer Res. 2020;80:5543-5553.
    PubMed     Abstract available

    November 2020
  10. ARUMOV A, Liyanage PY, Trabolsi A, Roberts ER, et al
    Optimized doxorubicin chemotherapy for diffuse Large B-Cell lymphoma exploits nanocarrier delivery to transferrin receptors.
    Cancer Res. 2020 Nov 11. pii: 0008-5472.CAN-20-2674.
    PubMed     Abstract available

    October 2020
  11. TATEISHI K, Miyake Y, Kawazu M, Sasaki N, et al
    A hyperactive RelA/p65-hexokinase 2 signaling axis drives primary central nervous system lymphoma.
    Cancer Res. 2020 Oct 16. pii: 0008-5472.CAN-20-2425.
    PubMed     Abstract available

    September 2020
  12. SUGIHARA E, Hashimoto N, Osuka S, Shimizu T, et al
    The inhibitor of apoptosis protein Livin confers resistance to Fas-mediated immune cytotoxicity in refractory lymphoma.
    Cancer Res. 2020 Sep 14. pii: 0008-5472.CAN-19-3993.
    PubMed     Abstract available

    April 2020
  13. SAFFIE R, Zhou N, Rolland D, Onder O, et al
    FBXW7 triggers degradation of KMT2D to favor growth of diffuse large B-cell lymphoma cells.
    Cancer Res. 2020 Apr 29. pii: 0008-5472.CAN-19-2247.
    PubMed     Abstract available

    January 2020
  14. KLINGER M, Zugmaier G, Nagele V, Goebeler ME, et al
    Adhesion of T Cells to Endothelial Cells Facilitates Blinatumomab-Associated Neurologic Adverse Events.
    Cancer Res. 2020;80:91-101.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Malignant Lymphoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.